OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Organ Transplantation is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Delayed graft function: current status and future directions	71
Molecular matching tools for allocation and immunosuppression optimization. Ready for primetime?	46
Editorial: Organ Preservation Revolution: the future is revisiting the past through a different lens	25
Immunosuppression after uterus transplantation	22
HLA-DQ antibodies in alloimmunity, what makes them different?	22
The perspective for next-generation lung replacement therapies: functional whole lung generation by blastocyst complementation	21
Deceased donors with multidrug-resistant organisms: implications and future directions	20
Overview of pregnancy in solid-organ transplantation	19
Editorial introductions	19
Using organ perfusion to optimize donor livers	17
Update on surgical management of enteroatmospheric fistulae in intestinal failure patients	16
Urine CXCL10 as a biomarker in kidney transplantation	15
Obesity and kidney transplantation	14
Editorial introductions	13
What is needed to ensure long-term sustainability for the field of vascularized composite allotransplantation?	13
New insights into ischemia-reperfusion injury signaling pathways in organ transplantation	13
Equity in liver transplantation: are we any closer?	12
Modifying organs with gene therapy and gene modulation in the age of machine perfusion	12
Human cytomegalovirus: a survey of end-organ diseases and diagnostic challenges in solid organ transplant recipients	12
Role of T follicular helper and T follicular regulatory cells in antibody-mediated rejection: new therapeutic targets?	11
Update on combined heart and liver transplantation: evolving patient selection, improving outcomes, and outstanding questions	11
The ethics of donation after circulatory death organ recovery: an overview of new considerations arising from procurement practice and policy changes	11
Establishing an upper extremity transplantation program: lessons learnt over 12 years	10
Integrating risks and benefits: pretransplant assessment and patient selection for heart transplantation in adult congenital heart disease	10
Language and cultural concordance to promote equity in organ transplantation for Hispanics with limited English proficiency	9

Management of the sensitized heart transplant candidate	9
Respiratory viral infections including COVID-19 in solid organ transplantation	9
Uterus transplantation: the importance of uterine natural killer cells	8
Regulatory dendritic cell therapy in organ transplantation	8
Regulatory and transitional B cells: potential biomarkers and therapeutic targets in organ transplantation	8
Noninvasive methods to reduce cardiac complications postheart transplant	8
The sex disparity in liver transplantation	8
A cystic fibrosis patient	8
Beyond donation to organ utilization in the UK	8
Novel agents in the treatment of invasive fungal infections in solid organ transplant recipients	8
Cardiac evaluation of the liver transplant candidate	8
A review of transplant infectious diseases and pediatric transplant infectious diseases curriculum	7
Chronic rejection as a persisting phantom menace in organ transplantation: a new hope in the microbiota?	7
Ethical issues in organ procurement: donation after normothermic regional perfusion in liver transplantation	7
Social support and transplantation	7
Donor-derived infections in solid organ transplant recipients	7
Editorial: Uterus transplantation: the only curative treatment for absolute uterine factor infertility is moving forward	7
Future directions for xenotransplantation in lungs	7
The road to xenotransplantation	7
Machine perfusion in liver transplantation: recent advances and coming challenges	7
Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients	7
Microbiota in heart and lung transplantation: implications for innate-adaptive immune interface	7
Are split liver grafts a suitable option in high-risk liver transplant recipients?	7
Defining chronic rejection in vascularized composite allografts – do we have reliable surrogates to look for?	7
The role of living donor liver transplantation in colorectal cancer liver metastases	6
Lung preservation: from perfusion to temperature	6
Novel cell-based strategies for immunomodulation in vascularized composite allotransplantation	6
Normothermic regional perfusion for donation after circulatory death donors	6
Social and biologic determinants in lung transplant allocation	6
Ethical considerations in lung re-transplantation	6
Living liver donor pain management	6
Editorial introductions	6
Grasping time – longevity of vascularized composite allografts	6
Thoraco-abdominal normothermic regional perfusion for thoracic transplantation in the United States: current state and future directions	6
Pediatric intestinal rehabilitation	6
Management of long-term cardiovascular risk factors post organ transplant: Erratum	6
Nontransplant options for portomesenteric thrombosis	6
New insights into the microbiome in kidney transplantation	6
Unraveling the spectrum of airway complications following lung transplantation: a comprehensive overview	6
DSA in solid organ transplantation: is it a matter of specificity, amount, or functional characteristics?	5
Potential options to expand the intestinal donor pool: a comprehensive review	5
Editorial introductions	5
Robotic live donor hysterectomy	5
Uterus transplantation – donor and recipient work-up	5
Adherence in transplantation	5
Expanding MELD exceptions for colorectal liver metastasis: data and policy	5
Optimizing cardiac status in the preliver transplant candidate	5
The impact of the gut microbiome on liver transplantation	5
Liver transplantation for intrahepatic cholangiocarcinoma: who, when and how	5
Advances in desensitization for human leukocyte antigen incompatible kidney transplantation	5

Ethical considerations in access to heart transplant for adults with congenital heart disease	5
HIV in kidney transplantation	5
Preserving and rejuvenating old organs for transplantation: novel treatments including the potential of senolytics	5
Kidney organ allocation: reducing discards	5
Cell-free DNA in lung transplantation: research tool or clinical workhorse?	5
Editorial introductions	5
The history of ethical principles in liver transplant organ allocation in the United States: how historical and proposed allocations system fare in balancing utility vs. urgency and justice vs. pragma	5
Multidrug-resistant organisms in lung transplant: a narrative review	5
Editorial introduction	5